Robert Bissonnette Selected Research

XP-828l

12/2007	XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.
9/2006	XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Bissonnette Research Topics

Disease

60	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 07/2002
41	Atopic Dermatitis (Atopic Eczema) 12/2024 - 03/2010
14	Inflammation (Inflammations) 12/2023 - 01/2013
13	Eczema 12/2024 - 01/2018
11	Pruritus (Itching) 03/2023 - 09/2008
7	Hyperplasia 12/2023 - 10/2017
6	Actinic Keratosis 12/2012 - 07/2002
5	Infections 12/2023 - 07/2015
5	Acne Vulgaris 10/2019 - 11/2010
4	Skin Neoplasms (Skin Cancer) 01/2007 - 01/2004
3	Alopecia Areata 10/2023 - 12/2003
3	Headache (Headaches) 01/2023 - 07/2010
3	Neoplasms (Cancer) 03/2017 - 01/2004
2	Erythema 03/2024 - 01/2022
2	Pain (Aches) 02/2024 - 02/2023
2	Skin Diseases (Skin Disease) 03/2023 - 01/2023
2	Hypersensitivity (Allergy) 01/2023 - 01/2023
2	Folliculitis (Sycosis) 12/2021 - 01/2021
2	Nasopharyngitis 12/2021 - 08/2016
2	Necrosis 01/2020 - 03/2015
2	Communicable Diseases (Infectious Diseases) 12/2019 - 01/2019
2	Cicatrix (Scar) 10/2019 - 04/2018
2	Myocardial Infarction 10/2017 - 03/2010
2	Psoriatic Arthritis 05/2015 - 03/2015
2	Rheumatoid Arthritis 05/2015 - 03/2015
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2007 - 01/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2007 - 03/2004
1	Fatigue 02/2024
1	Chronic Disease (Chronic Diseases) 02/2024
1	Wounds and Injuries (Trauma) 12/2023

Drug/Important Bio-Agent (IBA)

11	dupilumabIBA 01/2023 - 01/2019
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
8	CytokinesIBA 03/2023 - 07/2009
8	Interleukin-17 (Interleukin 17)IBA 04/2021 - 07/2015
8	Adalimumab (Humira)FDA Link 01/2017 - 09/2009
7	tapinarofIBA 10/2022 - 04/2010
7	Prostaglandins AIBA 12/2021 - 09/2006
6	Monoclonal AntibodiesIBA 02/2024 - 07/2009
6	Etanercept (Enbrel)FDA Link 03/2017 - 09/2009
5	Immunoglobulin A (IgA)IBA 03/2024 - 04/2018
5	abrocitinibIBA 12/2023 - 12/2019
5	baricitinibIBA 10/2023 - 06/2021
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2010 - 07/2002
5	Alefacept (Amevive)FDA Link 12/2009 - 09/2009
4	Janus KinasesIBA 12/2024 - 08/2016
4	spesolimabIBA 02/2024 - 01/2022
4	Keratin-16 (Keratin 16)IBA 12/2023 - 01/2018
4	Janus Kinase 1IBA 10/2023 - 08/2016
4	Janus Kinase InhibitorsIBA 01/2023 - 08/2015
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2006
4	Ustekinumab (CNTO 1275)FDA Link 11/2021 - 09/2009
4	Interleukin-13IBA 01/2021 - 11/2017
4	Ointments (Pastes)IBA 11/2019 - 09/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2013
4	Aminolevulinic Acid (Levulan)FDA Link 01/2007 - 07/2002
3	ChemokinesIBA 12/2023 - 01/2017
3	InterleukinsIBA 03/2023 - 07/2015
3	diphenylcyclopropenoneIBA 01/2023 - 12/2003
3	pneumococcal purpura-producing principle (PPPP)IBA 01/2023 - 01/2016
3	LipidsIBA 11/2022 - 01/2018
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2022 - 04/2021
3	Infliximab (Remicade)FDA Link 01/2021 - 09/2009
3	VaccinesIBA 12/2019 - 01/2019
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019 - 07/2016
3	Benzoyl Peroxide FDA LinkGeneric 10/2019 - 04/2018
3	Adapalene (Differin)FDA LinkGeneric 10/2019 - 04/2018
3	RetinoidsIBA 08/2018 - 09/2009
3	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 10/2017 - 01/2010
2	ruxolitinibIBA 12/2024 - 05/2022
2	LigandsIBA 12/2023 - 04/2021
2	gusacitinibIBA 01/2023 - 10/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	crisaboroleIBA 01/2023 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 03/2015
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2017
2	Interleukin-22 (IL-22)IBA 01/2020 - 08/2015
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2019 - 09/2009
2	Calcineurin InhibitorsIBA 09/2019 - 03/2006
2	pimecrolimus (Elidel)FDA Link 09/2019 - 10/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2019 - 09/2008
2	loricrinIBA 01/2019 - 01/2018
2	Filaggrin ProteinsIBA 01/2019 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2019 - 11/2017
2	tofacitinibIBA 10/2016 - 08/2015
2	Tumor Necrosis Factor InhibitorsIBA 09/2016 - 05/2015
2	GlucocorticoidsIBA 05/2015 - 05/2015
2	Antirheumatic Agents (DMARD)IBA 05/2015 - 03/2015
2	Methotrexate (Mexate)FDA LinkGeneric 03/2015 - 09/2009
2	siplizumabIBA 07/2010 - 07/2009
2	XP-828lIBA 12/2007 - 09/2006
1	Peptides (Polypeptides)IBA 02/2024
1	Matrix Metalloproteinases (MMPs)IBA 12/2023
1	S100A12 ProteinIBA 12/2023
1	Calcium-Binding ProteinsIBA 12/2023

Therapy/Procedure

24	Therapeutics 02/2024 - 12/2003
6	Photochemotherapy (Photodynamic Therapy) 12/2012 - 01/2004
5	Phototherapy (Light Therapy) 11/2013 - 09/2004
4	Biological Therapy 06/2020 - 07/2009
3	Oral Administration 02/2024 - 09/2006